Therapeutic Classification: vascular headache suppressants
Pharmacologic Classification: five ht1 agonists
Absorption: Completely absorbed after oral administration, but first-pass metabolism results in 45% bioavailability.
Distribution: Unknown.
Half-Life: 23 hr.
Contraindicated in:
Use Cautiously in:
CV: chest pain, CORONARY ARTERY VASOSPASM, MI, myocardial ischemia, VENTRICULAR ARRHYTHMIAS
Derm: TOXIC EPIDERMAL NECROLYSIS
GI: dry mouth, nausea
Neuro: dizziness, drowsiness, weakness
Drug-drug:
Drug-Natural Products: